Compare LPTH & CERT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | LPTH | CERT |
|---|---|---|
| Founded | 1985 | 2008 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Semiconductors | Retail: Computer Software & Peripheral Equipment |
| Sector | Technology | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.1B | 1.1B |
| IPO Year | 2011 | 2020 |
| Metric | LPTH | CERT |
|---|---|---|
| Price | $11.41 | $6.97 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 3 | 10 |
| Target Price | ★ $13.33 | $11.67 |
| AVG Volume (30 Days) | 3.1M | ★ 4.6M |
| Earning Date | 05-14-2026 | 05-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 87.50 |
| EPS | N/A | ★ N/A |
| Revenue | $37,202,630.00 | ★ $418,838,000.00 |
| Revenue This Year | $83.04 | $4.18 |
| Revenue Next Year | $24.83 | $5.39 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ 17.26 | 8.75 |
| 52 Week Low | $2.91 | $4.45 |
| 52 Week High | $18.94 | $13.88 |
| Indicator | LPTH | CERT |
|---|---|---|
| Relative Strength Index (RSI) | 39.15 | 65.20 |
| Support Level | $10.06 | $5.93 |
| Resistance Level | $13.28 | $7.46 |
| Average True Range (ATR) | 1.31 | 0.41 |
| MACD | -0.34 | 0.03 |
| Stochastic Oscillator | 11.62 | 79.40 |
LightPath Technologies Inc manufactures, distributes, and integrates proprietary optical components and assemblies. It develops optical solutions for traditional optics and communications markets. The company's products include precision molded optics and infrared products, serving markets such as distribution, laser, industrial, instrumentation, telecommunications, and defense. Its products are categorized as infrared components, visible components, assemblies and modules, and engineering services. G5 Infrared's revenue mainly comes from infrared components and assemblies.
Certara Inc accelerates medicines to patients using biosimulation software and technology to transform traditional drug discovery and development. It provides modeling and simulation, regulatory science, and assessment software and services to help clients reduce clinical trials, accelerate regulatory approval, and increase patient access to medicines. The company has its business presence in the Americas, which is also its key revenue-generating market, EMEA, and the Asia Pacific region.